ClinicalTrials.gov
ClinicalTrials.gov Menu

ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00229684
Recruitment Status : Terminated (The development program has been terminated)
First Posted : September 30, 2005
Last Update Posted : August 30, 2011
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : June 2006